SI
PTCT icon

Sofinnova Investments’s PTC Therapeutics PTCT Stock Holding History

Sofinnova Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-186,932
Closed -$11.5M – 67
2025
Q3 		$11.5M Sell
186,932
-189,007
-50% -$9.84M 0.63% 41
2025
Q2 		$18.4M Sell
375,939
-203,400
-35% -$9.66M 1.12% 27
2025
Q1 		$29.5M Buy
+579,339
New +$28.9M 1.93% 15
2023
Q3 		– Sell
-260,443
Closed -$10.6M – 73
2023
Q2 		$10.6M Sell
260,443
-256,652
-50% -$12.6M 0.69% 30
2023
Q1 		$25M Buy
+517,095
New +$23.6M 1.6% 16
2022
Q2 		– Sell
-3,480
Closed -$130K – 67
2022
Q1 		$130K Sell
3,480
-128,968
-97% -$4.97M 0.01% 59
2021
Q4 		$5.28M Sell
132,448
-97,571
-42% -$3.73M 0.31% 54
2021
Q3 		$8.56M Sell
230,019
-351,921
-60% -$14.5M 0.51% 42
2021
Q2 		$24.6M Buy
581,940
+115,100
+25% +$4.93M 1.42% 16
2021
Q1 		$22.1M Buy
466,840
+150,362
+48% +$8.93M 1.33% 22
2020
Q4 		$19.3M Sell
316,478
-88,674
-22% -$5.23M 1.15% 20
2020
Q3 		$18.9M Sell
405,152
-33,118
-8% -$1.63M 1.4% 18
2020
Q2 		$22.2M Buy
438,270
+146,053
+50% +$7.18M 1.4% 18
2020
Q1 		$13M Sell
292,217
-224,875
-43% -$11.3M 1.21% 21
2019
Q4 		$24.8M Buy
517,092
+229,847
+80% +$9.77M 1.79% 13
2019
Q3 		$9.71M Sell
287,245
-81,658
-22% -$3.55M 0.88% 29
2019
Q2 		$16.6M Buy
+368,903
New +$14.6M 1.53% 15
2018
Q3 		– Sell
-127,079
Closed -$4.29M – 63
2018
Q2 		$4.29M Buy
127,079
+101,350
+394% +$3.16M 0.49% 37
2018
Q1 		$696K Buy
+25,729
New +$652K 0.12% 24

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sofinnova Investments's PTCT Position: Q4 2025 in Review

Sofinnova Investments sold out of PTC Therapeutics (PTCT) in Q4 2025, closing a stake of 186,932 shares — an estimated $11.5M sold.

Sofinnova Investments first reported a position in PTCT in Q1 2018 and held it in 19 quarters. The position peaked at $29.5M in Q1 2025. 351 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.

  • Sofinnova Investments reported no remaining PTC Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Sofinnova Investments sold 186,932 PTC Therapeutics shares in Q4 2025, an estimated $11.5M.
  • Sofinnova Investments first reported a position in PTC Therapeutics in Q1 2018 and held it in 19 quarters.
  • Sofinnova Investments's PTC Therapeutics position peaked at $29.5M in Q1 2025.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.

Based on Sofinnova Investments's 13F filing for Q4 2025, filed 13 Feb 2026.